DiaGen AI leverages AI, ML, and data to advance human longevity through a proprietary platform and products.

DiaGen AI leverages AI, ML, and data to advance human longevity through a proprietary platform and products. We scale across three pillars: internal asset development, global partnerships with biotech and pharma experts, and the democratization of data and discovery via Bittensor. Our differentiators include 100+ years of combined expertise in AI, ML, and capital markets; a sharp focus on peptide and biomarker development for longevity; and a collaborative approach—partnering, not competing. With a global presence in Canada, USA, UK, EU, and UAE, and a first-mover advantage in decentralized intelligence, DiaGen AI is positioned to transform drug discovery and development.

Artificial Intelligence, Blockchain, Machine Learning, Big Data / Digitization / Analytics, Healthcare, Technology, Artificial Intelligence, Blockchain, HealthTech, Quantum & High Performance Computing, Robotics & Robotics Process Automation (RPA)